RxDoctor Payments Data

Panayiotis Varelas, MD

Neurology · Detroit, MINPI 1477628113

Payments from drug & device makers

$115,304in general payments, 2019–2025

Across 41 payments — averaging $2812.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$64K
  • UCB, Inc.$29K
  • Immedica Pharma US, Inc.$12K
  • UCB SA$5K
  • Portola Pharmaceuticals, LLC$2K
  • Biogen$1K
  • plus $2K from 5 others

What the payments were for

  • Consulting fees$43,72591%
  • Speaking & faculty fees$2,2185%
  • Travel & lodging$1,1532%
  • Food & beverage$7592%
  • Education$130%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)10$63,727
UCB, Inc.10$29,433
Immedica Pharma US, Inc.5$12,072
UCB SA1$5,400
Portola Pharmaceuticals, LLC2$1,863
Biogen1$1,000
Astrazeneca UK Limited8$749
Voxneuro USA Inc.1$500
Irras USA, Inc.1$468
Sanofi1$79
Argenx US, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,304 in reported general payments places this provider in the 85th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$52,816
Medicare patients
160
Services billed
438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →